RxDoctor Payments Data

Patricia Mooney

Nurse Practitioner · San Marcos, CANPI 1700470200

Payments from drug & device makers

$9,500in general payments, 2019–2025

Across 390 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$926
  • Merck$606
  • Pharmacyclics LLC, An Abbvie Company$448
  • Novartis$430
  • GSK$370
  • Sanofi$367
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,21897%
  • Education$2823%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)32$926
Merck29$606
Pharmacyclics LLC, An Abbvie Company19$448
Novartis20$430
GSK17$370
Sanofi11$367
Pfizer16$354
Amgen7$339
AbbVie13$296
Daiichi Sankyo Inc.14$293
Gilead(2 entities)12$289
Bristol Myers Squibb11$282
AstraZeneca13$256
Caris MPI, Inc.4$224
Puma Biotechnology, Inc.7$181
Deciphera Pharmaceuticals Inc.4$177
Eisai Inc.7$176
Regeneron Healthcare Solutions, Inc.6$175
Takeda Pharmaceuticals U.S.A., Inc.7$174
Incyte Corporation7$163
Genentech USA, Inc.10$157
Sobi, Inc5$140
Astellas Pharma US Inc7$140
Ipsen Biopharmaceuticals, Inc6$125
Pharmaessentia USA Corporation4$122
Exelixis Inc.4$119
Bayer6$115
Array Biopharma Inc6$112
Blueprint Medicines Corporation5$110
Taiho Oncology, Inc.4$100
E.r. Squibb & Sons, L.L.C.5$99
EMD Serono, Inc.4$99
Servier Pharmaceuticals LLC4$90
Boehringer Ingelheim3$87
Beigene USA, Inc.4$85
Beone Medicines USA, Inc.3$76
Genmab U.S., Inc.3$75
Agios Pharmaceuticals, Inc.3$67
Morphosys, US Inc.3$62
Acrotech Biopharma Inc.3$55
Lilly USA, LLC3$55
AVEO Pharmaceuticals, Inc.3$55
Tempus AI, Inc2$54
Mirati Therapeutics, Inc.2$53
Tersera Therapeutics LLC2$49
Iovance Biotherapeutics, Inc.2$46
Dova Pharmaceuticals2$46
Coherus Oncology, Inc.2$41
Octapharma USA, Inc.2$40
Azurity Pharmaceuticals, Inc.1$33
GE HealthCare1$32
Novocure Inc.1$31
Syndax Pharmaceuticals, Inc.1$30
ADC Therapeutics America, Inc.1$29
Accord Healthcare, Inc.1$27
EUSA Pharma (US) LLC1$27
Legend Biotech USA Inc.1$27
Stemline Therapeutics Inc.1$25
Catalyst Pharmaceuticals, Inc.1$25
Rigel Pharmaceuticals, Inc.1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,500 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$172,288
Medicare patients
69
Services billed
7,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron22$327
Prochlorperazine Maleate22$232
Dexamethasone11$199
Gabapentin12$170

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in San Marcos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →